1-Cyclopropyl-6,7-difluoro-1,4-dihydro-8-methyl-4-oxo-3-quinolinecarboxylic acid | 112822-92-1

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 喹啉及其衍生物
• 英文名称: 1-Cyclopropyl-6,7-difluoro-1,4-dihydro-8-methyl-4-oxo-3-quinolinecarboxylic acid
• 英文别名: 1-Cyclopropyl-6,7-difluoro-1,4-dihydro-8-methyl-4-oxoquinoline-3-carboxylic Acid；1-Cyclopropyl-6,7-difluoro-8-methyl-4-oxo-1,4-dihydroquinoline-3-carboxylic acid；1-cyclopropyl-6,7-difluoro-8-methyl-1,4-dihydro-4-oxoquinoline-3-carboxylic acid；7-fluoro-1-cyclopropyl-6-fluoro-8-methyl-4-oxo-1,4-dihydro-quinoline-3-carboxylic acid；1-cyclopropyl-6,7-difluoro-8-methyl-4-oxoquinoline-3-carboxylic acid
• CAS: 112822-92-1
• 化学式: C₁₄H₁₁F₂NO₃
• 分子量: 279.243
• InChiKey: WATLIFHZDGFZNO-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.1
• 重原子数：
  20
• 可旋转键数：
  2
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.29
• 拓扑面积：
  57.6
• 氢给体数：
  1
• 氢受体数：
  6

反应信息

• 作为反应物：
  描述：

  1-Cyclopropyl-6,7-difluoro-1,4-dihydro-8-methyl-4-oxo-3-quinolinecarboxylic acid 生成 7-(1-piperazinyl)-1-cyclopropyl-6-fluoro-8-methyl-1,4-dihydro-4-oxoquinoline-3-carboxylic acid
  参考文献：
  名称：

  MASUZAWA, KUNIYOSHI;SUZUE, SEIGO;HIRAI, KEIJI;ISHIZAKI, TAKAYOSHI

  摘要：

  DOI：
• 作为产物：
  描述：

  Ethyl 1-Cyclopropyl-6,7-difluoro-1,4-dihydro-8-methyl-4-oxoquinoline-3-carboxylate 在 盐酸 、 溶剂黄146 作用下， 反应 2.0h， 以89%的产率得到1-Cyclopropyl-6,7-difluoro-1,4-dihydro-8-methyl-4-oxo-3-quinolinecarboxylic acid
  参考文献：
  名称：

  抗菌剂的研究。三，取代的1,4-二氢-8-甲基-4-氧代喹啉-3-羧酸的合成及抗菌活性。

  摘要：

  制备一系列在8位具有甲基的取代的4-氧代喹啉-3-羧酸，并测试其抗菌活性。7-（反式-3-氨基-4-甲基-1-吡咯烷基）-1-环丙基-1,4-二氢-6-氟-8-甲基-4-氧喹啉-3-羧酸（21）表现出强效对革兰氏阳性和革兰氏阴性细菌（包括铜绿假单胞菌）均具有抗菌活性。

  DOI：

  10.1248/cpb.38.2472

文献信息

• [EN] QUINOLONE ANTIBACTERIAL AGENTS<br/>[FR] AGENTS ANTIBACTERIENS A LA QUINOLONE
  申请人：WARNER LAMBERT CO

  公开号：WO2005049602A1

  公开（公告）日：2005-06-02

  Compounds of formula (I) wherein A is formula (II), formula (III) or formula (IV), and B is formula (V), formula (VI), or formula (VII), can be used in a variety of applications including use as antibacterial agents.

  式(I)的化合物中，其中A是式(II)，式(III)或式(IV)，B是式(V)，式(VI)或式(VII)，可用于各种应用，包括用作抗菌剂。
• Spiro compound
  申请人：Daiichi Seiyaku Co., Ltd.

  公开号：US05286723A1

  公开（公告）日：1994-02-15

  The present invention relates to spiro compounds of general formula I: ##STR1## wherein the substituents are herein below defined. The present invention relates to antibacterial spiro compounds which are of value as drugs for humans, veterinary drugs or drugs for use in fish culture or as preservatives, and to antibacterial compositions containing one or more of the same compounds as active ingredients.

  本发明涉及通式I的螺环化合物：##STR1##其中取代基如下定义。本发明涉及具有抗菌作用的螺环化合物，可作为人类药物、兽药或用于鱼类养殖的药物，或作为防腐剂，以及含有同一化合物中一种或多种作为活性成分的抗菌组合物。
• Benzoheterocyclic compounds
  申请人：Otsuka Pharmaceutical Company, Limited

  公开号：US04874764A1

  公开（公告）日：1989-10-17

  Novel 4-oxoquinoline-3-carboxylic acid compounds of the formula: ##STR1## wherein R.sup.3 is C.sub.1 -C.sub.6 alkyl and R.sup.F is C.sub.1 -C.sub.6 alkyl, and a pharmaceutically acceptable salts thereof, said compounds having excellent antimicrobial activity and hence being useful as an antimicrobial agent, and a pharmaceutical composition containing said compound as an active ingredient.

  具有优异抗微生物活性的化合物为4-氧喹啉-3-羧酸类化合物，其化学式为：##STR1## 其中R.sup.3为C.sub.1 -C.sub.6烷基，R.sup.F为C.sub.1 -C.sub.6烷基，以及其药学上可接受的盐。这些化合物可用作抗微生物剂，并且包含该化合物作为活性成分的药物组合物。
• 1-Cyclopropyl-6-fl
  申请人：Otsuka Pharmaceutical Company, Limited

  公开号：US04880806A1

  公开（公告）日：1989-11-14

  Novel 4-oxoquinoline-3-carboxylic acid compounds of the formula: ##STR1## wherein R.sup.2 is a heterocyclic group: ##STR2## in which R.sup.A is H, C.sub.1 -C.sub.6 alkyl or phenyl (C.sub.1 -C.sub.6) alkyl, R.sup.B is 2-oxo-1,3-dioxolenemethyl substituted by C.sub.1 -C.sub.6 alkyl, or C.sub.3 -C.sub.8 cycloalkyl, R.sup.C is H, C.sub.1 -C.sub.6 alkyl, C.sub.1 -C.sub.6 alkoxycarbonyl, or phenyl(C.sub.1 -C.sub.6)alkyl, R.sup.D is H or C.sub.1 -C.sub.6 alkyl, R.sup.G is C.sub.1 -C.sub.6 alkyl, and R.sup.H is C.sub.1 -C.sub.6 alkyl, phenyl(C.sub.1 -C.sub.6)alkyl, or C.sub.1 C.sub.6 alkanoyl, and R.sup.3 is C.sub.1 -C.sub.6 alkyl, or R.sup.3 is C.sub.1 -C.sub.6 alkyl having 1 to 3 substituents selected from OH, C.sub.1 -C.sub.6 alkoxy and halogen when R.sup.2 is ##STR3## or a salt thereof, said compounds having excellent antimicrobial activity and being useful as an antimicrobial agent, and a pharmaceutical composition containing said compound as an active ingredient.

  4-氧喹啉-3-羧酸衍生物的化学式：其中R.sup.2是一个杂环基团：在其中R.sup.A为H，C.sub.1 -C.sub.6烷基或苯基（C.sub.1 -C.sub.6）烷基，R.sup.B是2-氧代-1,3-二氧杂环戊烯甲基，被C.sub.1 -C.sub.6烷基或C.sub.3 -C.sub.8环烷基取代，R.sup.C是H，C.sub.1 -C.sub.6烷基，C.sub.1 -C.sub.6烷氧羰基，或苯基（C.sub.1 -C.sub.6）烷基，R.sup.D是H或C.sub.1 -C.sub.6烷基，R.sup.G是C.sub.1 -C.sub.6烷基，R.sup.H是C.sub.1 -C.sub.6烷基，苯基（C.sub.1 -C.sub.6）烷基，或C.sub.1 -C.sub.6酰基，R.sup.3是C.sub.1 -C.sub.6烷基，或R.sup.3是C.sub.1 -C.sub.6烷基，具有1至3个取代基，所选自OH，C.sub.1 -C.sub.6烷氧基和卤素，当R.sup.2是##STR3##或其盐，所述化合物具有出色的抗菌活性，可用作抗菌剂，并且含有所述化合物作为活性成分的药物组合物。
• 1-cyclopropyl-6-fluoro-8-alkyl-1,4-dihydro-4-oxo-quinoline-3-carboxylic
  申请人：Otsuka Pharmaceutical Company, Limited

  公开号：US04855292A1

  公开（公告）日：1989-08-08

  Novel 4-oxoquinoline-3-carboxylic acid compounds of the formula: ##STR1## wherein R.sup.2 is 1-pyrrolidinyl which may have 1 to 2 substituents selected from the group consisting of (i) C.sub.1 -C.sub.6 alkyl, (ii) amino-(C.sub.1 -C.sub.6)alkyl, said amino being optionally substituted by 1 or 2 substituents selected from C.sub.1 -C.sub.6 alkyl, C.sub.1 -C.sub.6 alkanoyl, and C.sub.1 -C.sub.6 alkoxycarbonyl, (iii) amino which may be substituted by 1 or 2 substituents selected from C.sub.1 -C.sub.6 alkyl, phenyl(C.sub.1 -C.sub.6)alkyl, C.sub.1 -C.sub.6 alkoxycarbonyl, and C.sub.1 -C.sub.6 alkanoyl, and (iv) 2-oxo-1,3-dioxolenemethylamino which is substituted by C.sub.1 -C.sub.6 alkyl; or 1-piperidinyl which may have 1 to 3 substituents selected from oxo, hydroxy, halogen and C.sub.1 -C.sub.6 alkyl, and R.sup.3 is C.sub.1 -C.sub.6 alkyl, or a pharmaceutically acceptable salt thereof, said compounds having excellent antimicrobial activity and hence being useful as an antimicrobial agent, and a pharmaceutical composition containing said compound as an active ingredient.

  4-氧喹啉-3-羧酸化合物的结构式：其中R.sup.2为1-吡咯烷基，可以有1到2个取代基，所选自以下组合：(i) C.sub.1-C.sub.6烷基，(ii) 氨基-(C.sub.1-C.sub.6)烷基，该氨基可以选为1或2个取代基，所选自C.sub.1-C.sub.6烷基，C.sub.1-C.sub.6烷酰基和C.sub.1-C.sub.6氧代羰基，(iii) 氨基，可以被1或2个取代基所取代，所选自C.sub.1-C.sub.6烷基，苯基(C.sub.1-C.sub.6)烷基，C.sub.1-C.sub.6氧代羰基和C.sub.1-C.sub.6烷酰基，以及(iv) 2-氧代-1,3-二氧杂环戊烯基氨基，该氨基被C.sub.1-C.sub.6烷基取代；或1-哌啶基，可以有1到3个取代基，所选自氧代、羟基、卤素和C.sub.1-C.sub.6烷基，R.sup.3为C.sub.1-C.sub.6烷基，或其药学上可接受的盐，这些化合物具有出色的抗微生物活性，因此可用作抗微生物药物，并且含有该化合物作为活性成分的药物组合物。